Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2013
10/22/2013CA2497884C Therapeutic human anti-il-1r1 monoclonal antibody
10/22/2013CA2412626C Il-17 molecules and uses thereof
10/22/2013CA2359926C Antagonists of hmg1 for treating inflammatory conditions
10/17/2013WO2013155447A1 Tiki inhibitors
10/17/2013WO2013154760A1 Chimeric antigen receptors targeting b-cell maturation antigen
10/17/2013WO2013154460A1 Nano-antibody specifically binding cea protein, and method for using said nano-antibody for detecting said protein
10/17/2013WO2013154206A1 Anti-fgfr2 antibody
10/17/2013WO2013153189A1 Anti-adamts-5 antibody, derivatives and uses thereof
10/17/2013WO2013152919A1 Detection of platelet-derived shed cd31
10/17/2013WO2013152860A2 Improved antibody light chains
10/17/2013WO2013119966A3 Single-chain antibodies and other heteromultimers
10/17/2013WO2013040472A8 Compositions and methods related to dna damage repair
10/17/2013WO2012156018A8 Antibodies for treatment of cancer expressing claudin 6
10/17/2013WO2012096994A3 Antibodies directed against influenza
10/17/2013WO2012054084A3 Antibodies
10/17/2013US20130274450 Binding proteins specific for insulin-like growth factors and uses thereof
10/17/2013US20130274449 Anti-CD100 Neutralizing Antibodies and Methods of Using the Same
10/17/2013US20130274448 Method for preventing myocardial infarction-related complications
10/17/2013US20130274447 Humanized antibodies against cxcr3
10/17/2013US20130274446 Fragment of humanized anti-egfr antibody substituted-lysine variable fragment and use thereof
10/17/2013US20130274203 Anti-ssx-2 t cell receptors and related materials and methods of use
10/17/2013US20130274199 Partial Fragment of REIC/Dkk-3 Gene and Cancer Therapeutic Agent Comprising the Same
10/17/2013US20130274112 Ligand screening and discovery
10/17/2013US20130273581 Haptens and immunoreactive agents and use thereof for producing family antibodies and immunoassays for quinolones
10/17/2013US20130273553 Stabilization of cyclic peptide structures
10/17/2013US20130273077 Antibodies to ntb-a
10/17/2013US20130273075 Compounds and Method for Modulating Inflammatory Reactions
10/17/2013US20130273073 Therapeutic Antibodies against ROR-1 Protein and Methods for Use of Same
10/17/2013US20130273072 Fully human therapeutic antibodies specific for human cd38
10/17/2013US20130273071 Recombinant IL-9 Antibodies And Uses Thereof
10/17/2013US20130273069 Pcsk9 antagonists
10/17/2013US20130273068 Antibodies
10/17/2013US20130273064 Antibodies against a proliferating inducing ligand (april)
10/17/2013US20130273062 Antibodies against human cd39 and use thereof
10/17/2013US20130273060 Novel antibodies inhibiting c-met dimerization, and uses thereof
10/17/2013US20130273059 Purified antibody composition
10/17/2013US20130273056 Tyrosine-phosphorylated wbp2, a novel cancer target and biomarker
10/17/2013US20130273055 Agents and methods for treating diseases that correlate with bcma expression
10/17/2013US20130273054 Bispecific Anti ErbB2/Anti cMet Antibodies
10/17/2013US20130273053 Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Paroxysmal Nocturnal Hemoglobinuria
10/17/2013US20130273052 Polypeptides that bind to human complement component c5
10/17/2013US20130273051 Methods for the development of metzincin-selective catalytic cleft directed antibodies for therapeutic and diagnostic applications
10/17/2013US20130273050 Pharmaceutical compositions with resistance to soluble cea
10/17/2013US20130273049 Robo1-fc fusion protein for use in the treatment of hepatocarcinoma
10/17/2013US20130273047 Clotting Factor-Fc Chimeric Proteins to Treat Hemophilia
10/17/2013US20130273044 Compositions and Methods for Diagnosing and Treating Cancer
10/17/2013US20130273043 Optimized Fc Variants
10/17/2013US20130273042 Treatment of multiple sclerosis
10/17/2013US20130273041 Use of chimeric anti-cd20 antibody as in vitro or in vivo purging agent in patients receiving bmt or pbsc transplant
10/17/2013US20130273040 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
10/17/2013US20130273039 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody
10/17/2013US20130273038 Human cdr-grafted antibody and antibody fragment thereof
10/17/2013US20130273036 Fn14 Binding Proteins and Uses Thereof
10/17/2013US20130273033 Humanized egfr antibodies
10/17/2013US20130273031 Novel anti-igf-ir antibodies and uses thereof
10/17/2013US20130273029 Antibodies for epidermal growth factor receptor 3 (her3) directed to domain ii of her3
10/17/2013US20130272964 Molecules with extended half-lives, compositions and uses thereof
10/17/2013US20130272958 Anti-ceacam6 antibodies and uses thereof
10/17/2013US20130272957 Novel antibodies inhibiting c-met dimerization, and uses thereof
10/16/2013EP2650367A1 Human monoclonal antibody
10/16/2013EP2650311A2 Amino acid sequences directed against heterodimeric cytokines and/or their receptors and polypeptides comprising the same
10/16/2013EP2650310A1 Anti-adamts-5 antibody, derivatives and uses thereof
10/16/2013EP2650309A1 Conjugate of folate and antibody, preparation method and use thereof
10/16/2013EP2650308A2 Use of anti-amyloid beta antibody in ocular diseases
10/16/2013EP2650307A1 IMMUNOLOGICAL cofilin-1 PROTEIN MEASUREMENT METHOD
10/16/2013EP2650306A1 Humanized Anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
10/16/2013EP2650017A2 Alpha 5 - beta 1 antibodies and their uses
10/16/2013EP2649995A2 Inhibition of post-radiation tumor growth
10/16/2013EP2649452A1 Method and case for the in vitro diagnosis of prostate cancer
10/16/2013EP2649189A1 Tnf- binding proteins
10/16/2013EP2649184A1 Fertile transgenic animals useful for producing antibodies bearing human variable regions
10/16/2013EP2649098A1 Antibodies against ror1 and uses thereof
10/16/2013EP2649097A1 Anti ccr4 antibodies and uses thereof
10/16/2013EP2648754A2 Methods of inhibiting metastasis from cancer
10/16/2013EP2648752A2 Humanized antibodies to liv-1 and use of same to treat cancer
10/16/2013EP2648749A2 Novel modulators and methods of use
10/16/2013EP2648748A1 Novel modulators and methods of use
10/16/2013EP2648747A1 Antitumor combinations containing antibodies recognizing specifically cd38 and bortezomib
10/16/2013EP2648744A2 Malaria vaccines based on pre-erythrocytic antigens from p. falciparum
10/16/2013EP2648735A2 Granzyme b inhibitor compositions, methods and uses for promoting wound healing
10/16/2013EP2648734A1 Methods of metabolic targeting cancer cells using che mo- and immunotherapy for treating cancer
10/16/2013EP2399937A9 Anti-human alpha9 integrin antibody and use thereof
10/16/2013CN103352028A Hybridoma cell strain YNEMC3, monoclonal antibody generated thereby, and application of monoclonal antibody
10/16/2013CN103351438A Anti-cmet antibody
10/16/2013CN103351437A Lingo binding molecules and pharmaceutical use thereof
10/16/2013CN103351436A Monoclonal antibody capable of recognizing 6 amino acid tags and preparation method and application thereof
10/16/2013CN103351435A Human binding molecules having killing activity against staphylococci and uses thereof
10/16/2013CN103351434A Optimized fc variants
10/16/2013CN103351433A Benzoic acid artificial antigen and antibody, and preparation methods and applications thereof
10/16/2013CN103349781A Modified chimeric polypeptides with improved pharmacokinetic properties
10/16/2013CN102827274B Hepatitis B vaccine antibody and chip containing antibody
10/16/2013CN102559689B Prawn complement 1q binding protein and application thereof
10/16/2013CN102504026B Full human single chain antibody capable of resisting epidermal growth-factor receptor and application thereof
10/16/2013CN102477412B Anti-porcine parvovirus (PPV) monoclonal antibody and application thereof
10/16/2013CN102455357B Kit and method for detecting beta-lactamase
10/16/2013CN102321174B IL-31 monoclonal antibodies and methods of use
10/16/2013CN101936984B Method and special chemical luminous immunoassay kit for detecting clenbuterol
10/16/2013CN101900724B Method for identifying cordyceps sinensis phorozoon by using immunohistochemistry
10/16/2013CN101806804B Reagent for detecting acute myocardial infarction by immunological method and test strip
10/16/2013CN101711256B Antibodies against IL-25
1 ... 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 ... 1494